A Phase III Study to Evaluate the Efficacy and Safety of Fruquitinib in Combination With Paclitaxel Versus Paclitaxel Alone in Second Line Gastric Cancer
Phase of Trial: Phase III
Latest Information Update: 13 Nov 2017
At a glance
- Drugs Fruquintinib (Primary) ; Paclitaxel
- Indications Gastric cancer; Oesophageal cancer
- Focus Registrational; Therapeutic Use
- Acronyms FRUTIGA
- Sponsors Hutchison MediPharma
- 31 Oct 2017 Status changed from not yet recruiting to recruiting, according to a Chi-Med media release.
- 31 Jul 2017 According to a Chi-Med media release, Phase III trial will be initiated in late 2017 or early 2018 in China.
- 18 Jul 2017 Status changed from planning to not yet recruiting.